The US Commodity Futures Trading Commission (CFTC) has paused approval of futures tied to AI accelerator rental prices: exchanges had planned to launch such trading this fall, but the regulator fears manipulation in an opaque market. While AI companies' computing costs remain without exchange-based hedging, platforms are moving toward monetizing chatbots: OpenAI has opened a beta platform, Businesses in ChatGPT, with agents and advertising for brands, Anthropic has turned Claude into an office suite for non-technical employees, and Google DeepMind has introduced the conditional genomic model AlphaGenome 2, available via API for non-commercial research.


What happened
According to the Financial Times, the CFTC has paused approval of futures tied to AI accelerator rental prices. Exchanges were preparing to start trading futures on indices from startup SiliconData in the fall, but the regulator fears manipulation: the accelerator rental market is opaque, dominated by a narrow circle of suppliers, and low-liquidity indices can easily be distorted by fictitious trades. On November 10, OpenAI launched the beta platform Businesses in ChatGPT: through Business Hub, companies verify their profile, upload product catalogs with prices, and receive anonymous statistics on mentions and clicks, while Business Agents allow starting a dialogue with a brand agent directly from a ChatGPT response and promoting it via the ChatGPT Ads format; the beta is available only to US e-commerce and online services. Anthropic released the Claude office suite: Meetings, Sheets, and Whiteboards tools are in beta for paid and enterprise subscribers, Claude Data is available in general release, and MCP connectors link the model with HubSpot, Adobe, and Atlassian. On November 11, Google DeepMind introduced AlphaGenome 2, a model for deciphering how cells read DNA: it was trained on more than 107 million cellular profiles from 68 tissues and, on the TenK10K dataset, increases the share of identified causal variants from 16% to 30% compared to its first version.
Context
Futures on AI accelerator rentals were conceived as insurance for the industry: they would allow startups to lock in computing costs in advance, the main expense item. Exchanges and venture funds like Andreessen Horowitz were already betting on such an instrument, but the regulator approaches it with the same rigor as classic commodity indices: the price must be formed transparently so it cannot be moved by trades that do not reflect real demand. The product lines of OpenAI and Anthropic follow a different logic: both companies are monetizing chatbots as a work environment and sales channel. OpenAI is building a brand showcase with agents and advertising inside ChatGPT, while Anthropic is targeting non-technical office employees for the first time and entering direct competition with Google Workspace and Microsoft 365. AlphaGenome 2 stands apart in this lineup: it is a scientific-level claim where the model moves from a universal expression predictor to conditional generation of biological contexts. The scale of its training is available only to players with consortium-level data, so open access, rather than blog claims, is crucial for independent verification.
Why this matters for the industry
The CFTC pause delays the transformation of GPU rentals into an exchange-traded asset: hedging the main expense of ML teams, computing, is currently impossible, and AI startups still have to factor in price volatility for compute power in their plans. If the futures market is eventually approved after transparency is established, computing costs will become a hedgeable budget item and change long-term capacity planning. Simultaneously, new distribution surfaces are opening for builders: catalogs and Business Agents inside ChatGPT, the ChatGPT Ads format, and Anthropic's MCP connectors to HubSpot, Adobe, and Atlassian. If the betas reach general release, engineers will have to maintain these integration points, the first wave of "generative SEO" is expected around Business Hub metrics, and Anthropic's MCP layer will likely become the main testing ground for office integrations. AlphaGenome 2 sets a template for conditional domain models of "sequence plus biological context": if results are confirmed, demand will arise for similar models for other modalities.
Why this matters for users
Laboratories can already run direct experiments on their own RNA sequencing data: AlphaGenome 2 requires a profile of just a few dozen cells, and adaptation happens without fine-tuning. If independent groups confirm this operating mode, the barrier to entry for research groups without their own infrastructure and large datasets will drop sharply. US companies can register in Business Hub and see how often ChatGPT mentions their site and how many readers click through links. Paid and enterprise Claude subscribers get Meetings, Sheets, and Whiteboards in beta, and these tools are addressed for the first time not to engineers, but to regular office employees. For readers, the futures story explains why "GPU rental price" may become not just an expense item but an exchange instrument in the coming months—or not, due to the regulator.
What is still unknown / limitations
The CFTC story relies on a Financial Times article, available only behind a paywall, and has not been independently verified: it is unclear from sources whether the pause applies to all applications and how long it will last. The claimed "almost double" increase for AlphaGenome 2 was obtained on a single dataset, TenK10K, and compares the new model only with its own first version: no external baselines, definition of "causality," or evaluation protocol are described in the sources, so conclusions about a real shift require independent checks. For Businesses in ChatGPT, ChatGPT Ads, Business Agents, and Claude office tools, prices, limits, and latency metrics have not been published, there is no methodology or benchmarks, and access is limited by geography and subscription type.
Sources
- Introducing Businesses in ChatGPT — OpenAI
- AlphaGenome 2: Deciphering how cells read DNA to better understand disease — Google DeepMind
- Anthropic has its own AI-powered office suite now — The Verge
Author
Look at AI, editorial team
